|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Current assets: | ||||||
| Cash | ||||||
| Prepaid expense | ||||||
| Prepaid insurance, current portion | ||||||
| Total Current Assets | ||||||
| Prepaid insurance, net of current portion | ||||||
| Marketable securities held in Trust Account | ||||||
| Deferred offering costs | ||||||
| Total Assets | ||||||
| Current Liabilities: | ||||||
| Accrued expenses | ||||||
| Accounts payable | ||||||
| Accounts payable and accrued expenses | ||||||
| Accrued offering cost | ||||||
| Promissory note – related party | ||||||
| Total Current Liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Ordinary shares subject to possible redemption, 11,500,000 shares at a redemption value of $10.48 and $10.20 per share at September 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit: | ||||||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 3,255,000 shares issued and outstanding at September 30, 2026 and December 31, 2025 | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities and Shareholders’ Deficit |
Loading...